OTCMKTS:IVOB

Invo Bioscience Stock Forecast, Price & News

$3.77
-0.08 (-2.08 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.75
Now: $3.77
$3.92
50-Day Range
$0.22
MA: $3.91
$9.40
52-Week Range
$0.11
Now: $3.77
$0.46
Volume124,410 shs
Average Volume43,036 shs
Market Capitalization$594.43 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.81
INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IVOB
CUSIPN/A
CIKN/A
Phone978-878-9505
Employees2
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$490,000.00
Book Value($0.02) per share

Profitability

Net Income$-3,080,000.00
Net Margins-166.95%

Miscellaneous

Market Cap$594.43 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Invo Bioscience Inc
March 10, 2021 |  reuters.com
INVO Bioscience Announces Closing of Financing
June 29, 2020 |  finance.yahoo.com
INVO Bioscience Reports 2019 Financial Results
March 30, 2020 |  finance.yahoo.com
INVO BioScience Inc.
March 25, 2020 |  www.barrons.com
See More Headlines

MarketRank

Overall MarketRank

0.52 out of 5 stars

Medical Sector

1535th out of 2,025 stocks

Surgical & Medical Instruments Industry

140th out of 169 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$3.77
-0.08 (-2.08 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

What stocks does MarketBeat like better than Invo Bioscience?

Wall Street analysts have given Invo Bioscience a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Invo Bioscience wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Invo Bioscience's earnings last quarter?

Invo Bioscience Inc (OTCMKTS:IVOB) posted its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.11 million for the quarter.
View Invo Bioscience's earnings history
.

How has Invo Bioscience's stock been impacted by Coronavirus (COVID-19)?

Invo Bioscience's stock was trading at $0.2288 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IVOB stock has increased by 1,547.7% and is now trading at $3.77.
View which stocks have been most impacted by COVID-19
.

Who are Invo Bioscience's key executives?

Invo Bioscience's management team includes the following people:
  • Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 64)
  • Mr. Robert Joseph Bowdring Jr., Acting CFO, Acting Principal Accounting Officer, Treasurer, Sec., Consultant & Director (Age 61)
  • Mr. Michael Jos. Campbell, COO, VP of Bus. Devel. & Director (Age 61)
  • Dr. Kevin Doody, Medical Director & Director (Age 58)

Who are some of Invo Bioscience's key competitors?

What other stocks do shareholders of Invo Bioscience own?

What is Invo Bioscience's stock symbol?

Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How do I buy shares of Invo Bioscience?

Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invo Bioscience's stock price today?

One share of IVOB stock can currently be purchased for approximately $3.77.

How much money does Invo Bioscience make?

Invo Bioscience has a market capitalization of $594.43 million and generates $490,000.00 in revenue each year.

How many employees does Invo Bioscience have?

Invo Bioscience employs 2 workers across the globe.

What is Invo Bioscience's official website?

The official website for Invo Bioscience is www.invobioscience.com.

Where are Invo Bioscience's headquarters?

Invo Bioscience is headquartered at 5582 BROADCAST COURT, SARASOTA FL, 34240.

How can I contact Invo Bioscience?

Invo Bioscience's mailing address is 5582 BROADCAST COURT, SARASOTA FL, 34240. The company can be reached via phone at 978-878-9505 or via email at [email protected]


This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.